NICE approves dabigatran in atrial fibrillation

on the 24 April 2012

Dabigatran etexilate (Pradaxa) can now be prescribed on the NHS to prevent stroke associated with atrial fibrillation (AF).

Pradaxa: only the 110mg and 150mg capsules are licensed for stroke prevention in patients with atrial fibrillation
Pradaxa: only the 110mg and 150mg capsules are licensed for stroke prevention in patients with atrial fibrillation

Dabigatran etexilate (Pradaxa), is recommended by the National Institute for Health and Care Excellence (NICE) as an option to prevent stroke and systemic embolism in patients with non-valvular AF who have ≥1 of the following risk factors:

  • Previous stroke, transient ischaemic attack or systemic embolism
  • Left ventricular ejection fraction <40%
  • Symptomatic heart failure (NYHA class II or above)
  • Age ≥75 years
  • Age ≥65 years with one of the following: diabetes, coronary artery disease or hypertension.

The thrombin inhibitor is also approved by NICE for the prevention of venous thromboembolic events in adults who have undergone elective total hip or knee replacement surgery.

Further details

NICE guidance on dabigatran for stroke prevention in AF

NICE guidance on dabigatran for VTE prevention

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

More from MIMS

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Ranitidine in short supply after contamination fears prompt precautionary recall

Ranitidine in short supply after contamination fears prompt precautionary recall

GPs have reported shortages of ranitidine following...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Alzhok and ranitidine oral soln.
Use our...

Excessive steroid dosing highlighted in inflammatory bowel disease

Excessive steroid dosing highlighted in inflammatory bowel disease

Some patients with Crohn's disease or ulcerative colitis...